785 related articles for article (PubMed ID: 16632067)
21. Diagnostic screening of NEUROD1 (MODY6) in subjects with MODY or gestational diabetes mellitus.
Sagen JV; Baumann ME; Salvesen HB; Molven A; Søvik O; Njølstad PR
Diabet Med; 2005 Aug; 22(8):1012-5. PubMed ID: 16026366
[TBL] [Abstract][Full Text] [Related]
22. [Molecular background and clinical characteristics of autosomal dominant type 2 diabetes mellitus].
Małecki M; Krolewski AS
Przegl Lek; 2000; 57 Suppl 3():13-8. PubMed ID: 11293229
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry.
Sagen JV; Bjørkhaug L; Molnes J; Raeder H; Grevle L; Søvik O; Molven A; Njølstad PR
Pediatr Diabetes; 2008 Oct; 9(5):442-9. PubMed ID: 18399931
[TBL] [Abstract][Full Text] [Related]
24. Identification of seven novel nucleotide variants in the hepatocyte nuclear factor-1alpha (TCF1) promoter region in MODY patients.
Godart F; Bellanné-Chantelot C; Clauin S; Gragnoli C; Abderrahmani A; Blanché H; Boutin P; Chèvre JC; Froguel P; Bailleul B
Hum Mutat; 2000; 15(2):173-80. PubMed ID: 10649494
[TBL] [Abstract][Full Text] [Related]
25. GCK and HNF1A mutations in Canadian families with maturity onset diabetes of the young (MODY).
Cao H; Shorey S; Robinson J; Metzger DL; Stewart L; Cummings E; Hegele RA
Hum Mutat; 2002 Dec; 20(6):478-9. PubMed ID: 12442280
[TBL] [Abstract][Full Text] [Related]
26. [Swiss journey through the clinical and genetic characteristics of diabetes in young patients].
Dussoix P; Tappy L; Philippe J
Schweiz Med Wochenschr; 1998 Jan; 128(5):162-6. PubMed ID: 9522422
[TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics, beta-cell function, HLA class II and mutations in MODY genes in non-paediatric subjects with Type 1 diabetes without pancreatic autoantibodies.
Aguilera E; Casamitjana R; Ercilla G; Oriola J; Nicoletti F; Gomis R; Conget I
Diabet Med; 2005 Feb; 22(2):137-43. PubMed ID: 15660729
[TBL] [Abstract][Full Text] [Related]
28. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity.
Hattersley AT
Diabet Med; 1998 Jan; 15(1):15-24. PubMed ID: 9472859
[TBL] [Abstract][Full Text] [Related]
29. Low prevalence of MODY2 and MODY3 mutations in Brazilian individuals with clinical MODY phenotype.
Furuzawa GK; Giuffrida FM; Oliveira CS; Chacra AR; Dib SA; Reis AF
Diabetes Res Clin Pract; 2008 Sep; 81(3):e12-4. PubMed ID: 18672310
[TBL] [Abstract][Full Text] [Related]
30. A novel Phe75fsdelT mutation in the hepatocyte nuclear factor-4alpha gene in a Danish pedigree with maturity-onset diabetes of the young.
Møller AM; Dalgaard LT; Ambye L; Hansen L; Schmitz O; Hansen T; Pedersen O
J Clin Endocrinol Metab; 1999 Jan; 84(1):367-9. PubMed ID: 9920109
[TBL] [Abstract][Full Text] [Related]
31. Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families.
Costa A; Bescós M; Velho G; Chêvre J; Vidal J; Sesmilo G; Bellanné-Chantelot C; Froguel P; Casamitjana R; Rivera-Fillat F; Gomis R; Conget I
Eur J Endocrinol; 2000 Apr; 142(4):380-6. PubMed ID: 10754480
[TBL] [Abstract][Full Text] [Related]
32. Proposed mechanism for a novel insertion/deletion frameshift mutation (I414G415ATCG-->CCA) in the hepatocyte nuclear factor 1 alpha (HNF-1 alpha) gene which causes maturity-onset diabetes of the young (MODY).
Ellard S; Bulman MP; Frayling TM; Shepherd M; Hattersley AT
Hum Mutat; 2000 Sep; 16(3):273. PubMed ID: 10980542
[TBL] [Abstract][Full Text] [Related]
33. Genetic variation in the hepatocyte nuclear factor (HNF)-3alpha gene does not contribute to maturity-onset diabetes of the young in Japanese.
Yu L; Wei Q; Jin L; Nishigori H; Nishigori T; Tomura H; Fujita J; Yamada Y; Seino Y; Takeda J
Horm Metab Res; 2001 Mar; 33(3):163-6. PubMed ID: 11355750
[TBL] [Abstract][Full Text] [Related]
34. MODY associated with two novel hepatocyte nuclear factor-1alpha loss-of-function mutations (P112L and Q466X).
Bjørkhaug L; Ye H; Horikawa Y; Søvik O; Molven A; Njølstad PR
Biochem Biophys Res Commun; 2000 Dec; 279(3):792-8. PubMed ID: 11162430
[TBL] [Abstract][Full Text] [Related]
35. [Non-insulin dependent diabetes in children and adolescents].
Njølstad PR; Søvik O; Bell GI; Cockburn BN; Følling I; Sagen J
Tidsskr Nor Laegeforen; 1998 Mar; 118(7):1054-7. PubMed ID: 9531829
[TBL] [Abstract][Full Text] [Related]
36. Identification of four novel mutations in the HNF-1A gene in Chinese early-onset and/or multiplex diabetes pedigrees.
Yang Z; Wu SH; Zheng TS; Lu HJ; Xiang KS
Chin Med J (Engl); 2006 Jul; 119(13):1072-8. PubMed ID: 16834925
[TBL] [Abstract][Full Text] [Related]
37. Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)?
Karlsson E; Shaat N; Groop L
Diabet Med; 2008 Jul; 25(7):788-91. PubMed ID: 18513302
[TBL] [Abstract][Full Text] [Related]
38. High frequency of mutations in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes.
Lehto M; Wipemo C; Ivarsson SA; Lindgren C; Lipsanen-Nyman M; Weng J; Wibell L; Widén E; Tuomi T; Groop L
Diabetologia; 1999 Sep; 42(9):1131-7. PubMed ID: 10447526
[TBL] [Abstract][Full Text] [Related]
39. Abnormal splicing of hepatocyte nuclear factor 1 alpha in maturity-onset diabetes of the young.
Bulman MP; Harries LW; Hansen T; Shepherd M; Kelly WF; Hattersley AT; Ellard S
Diabetologia; 2002 Oct; 45(10):1463-7. PubMed ID: 12378390
[TBL] [Abstract][Full Text] [Related]
40. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
Ellard S; Colclough K
Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
